Apyx Medical Corporation APYX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.16% | 49.20% | 71.93% | 57.81% | 42.37% |
| Total Depreciation and Amortization | 48.48% | 46.38% | 55.63% | 13.89% | -15.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.61% | -23.99% | -32.78% | -25.98% | -18.31% |
| Change in Net Operating Assets | -261.25% | -69.57% | -600.00% | -119.98% | 84.71% |
| Cash from Operations | -183.05% | 18.52% | 13.86% | 20.36% | 71.52% |
| Capital Expenditure | 75.09% | -9.09% | -12.24% | -239.22% | 8.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 75.09% | -9.09% | -12.24% | -239.22% | 8.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -20.00% | 20.00% | 0.00% |
| Issuance of Common Stock | -- | -- | 39.13% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -5.53% | -- | -- |
| Cash from Financing | -120.00% | 232.00% | 40.31% | 1,000.00% | 600.00% |
| Foreign Exchange rate Adjustments | 117.30% | -2,800.00% | -150.00% | -132.84% | -1,347.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.85% | 17.40% | 77.17% | 10.70% | 62.86% |